Celltrion Pharm Inc Cash Flow Reinvestment Rate
Celltrion Pharm Inc cash flow reinvestment rate. Celltrion Pharm Inc (068760) has a Cash Flow Reinvestment Rate of 0.95x as of September 2025, reinvesting ₩22.17 Billion (capex ₩2.27 Billion plus investments ₩-19.90 Billion) from operating cash flow of ₩23.44 Billion. Explore Celltrion Pharm Inc (068760) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Celltrion Pharm Inc (2014–2024)
Cash flow reinvestment rate of Celltrion Pharm Inc from 2014 to 2024. Historical reinvestment intensity for Celltrion Pharm Inc across 8 annual periods. Explore Celltrion Pharm Inc (068760) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Celltrion Pharm Inc Cash Flow Reinvestment Rate by Year (2014–2024)
Celltrion Pharm Inc cash flow reinvestment rate by year from 2014 to 2024. Year-by-year capital reinvestment analysis for Celltrion Pharm Inc. For the full cash flow conversion analysis, see 068760 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.32x | ₩18.10 Billion | ₩56.59 Billion | ₩5.98 Billion | ▼ -74.8% |
| 2023 | 1.27x | ₩11.12 Billion | ₩8.76 Billion | ₩6.90 Billion | ▲ +310.6% |
| 2021 | 0.31x | ₩28.81 Billion | ₩93.15 Billion | ₩12.50 Billion | ▼ -73.7% |
| 2020 | 1.18x | ₩42.61 Billion | ₩36.25 Billion | ₩41.98 Billion | ▼ -0.9% |
| 2019 | 1.19x | ₩33.06 Billion | ₩27.85 Billion | ₩30.49 Billion | ▲ +125.8% |
| 2018 | 0.53x | ₩7.52 Billion | ₩14.31 Billion | ₩7.21 Billion | ▼ -85.2% |
| 2015 | 3.55x | ₩47.38 Billion | ₩13.36 Billion | ₩45.97 Billion | ▲ +131.5% |
| 2014 | 1.53x | ₩26.53 Billion | ₩17.33 Billion | ₩26.16 Billion | — |